The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia (Q40009452)

16 September 2017

The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia (English)

1 reference

16 September 2017

1 reference

3

C Thiede

1 reference

16 September 2017

8

G Ehninger

1 reference

Study Alliance Leukemia (SAL)

16 September 2017

10

object named as

Study Alliance Leukemia (SAL)

1 reference

16 September 2017

H Seifert

1

1 reference

16 September 2017

B Mohr

2

1 reference

16 September 2017

U Oelschlägel

4

1 reference

16 September 2017

U Schäkel

5

1 reference

16 September 2017

T Illmer

6

1 reference

16 September 2017

S Soucek

7

1 reference

16 September 2017

M Schaich

9

1 reference

16 September 2017

8 January 2009

1 reference

16 September 2017

1 reference

16 September 2017

23

1 reference

16 September 2017

4

1 reference

16 September 2017

656-663

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2008.375

16 September 2017

0 references

cites work

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Live or let die: the cell's response to p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Mutated and non-mutated TP53 as targets in the treatment of leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Analysis of the p53 gene mutations in acute myelogenous leukemia: the p53 gene mutations associated with a deletion of chromosome 17

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Distinct genetic involvement of the TP53 gene in therapy-related leukemia and myelodysplasia with chromosomal losses of Nos 5 and/or 7 and its possible relationship to replication error phenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.375

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.375

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference